Source: Eur Respir J 2003; 22: 422-426
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
Dikmen G., Dikmen E., Kara M., Sahin E., Dogan P., Ozdemir N.. Diagnostic implications of telomerase activity in pleural effusions. Eur Respir J 2003; 22: 422-426

Member's Comments

No comment yet.

Related content which might interest you: Diagnostic implications of telomerase activity in pleural effusions Source: Eur Respir J 2004; 23: 653-654 Year: 2004 Comparison of telomerase activity in malignant and benign pleural effusions Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura Year: 2011 Clinical role of pleural effusion MMP-3 levels in malignant pleural mesothelioma Source: Annual Congress 2012 - Biology and treatment of malignant pleural effusions Year: 2012 Telomerase activity as additional diagnostic tool in pleural malignant effusions Source: Eur Respir J 2003; 22: Suppl. 45, 60s Year: 2003 Value of chitotriosidase enzyme activity in discrimination of tuberculous pleurisy from malignant pleural effusion Source: Annual Congress 2010 - Extrapulmonary tuberculosis Year: 2010 Diagnostic approach in a patient with pleural effusion Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=131 Year: 2002 Enzyme diagnosis of pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 51s Year: 2006 Pentraxin-3: A novel biomarker for the differentiation of parapneumonic effusion and malignant pleural effusion Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura Year: 2012 Lymphocytic pleural effusion. Can ADA levels in pleural fluid exclude malignancy? Source: Eur Respir J 2006; 28: Suppl. 50, 783s Year: 2006 Is the size of pleural effusion important in the study of patients whose first tumor manifestation is a pleural effusion? Source: International Congress 2017 – Pleural and mediastinal malignancies Year: 2017 Transudative malignant pleural effusions Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019 Cytology of pleural fluid versus histopathology of the pleura in the diagnosis of malignant pleural effusions Source: Eur Respir J 2006; 28: Suppl. 50, 775s Year: 2006 Diagnostic value of combined assays in differentiating tuberculous and malignant pleural effusions Source: Annual Congress 2008 - Genetics, immunology and microbiology of tuberculosis Year: 2008 Use of carcinoembryonic antigen in pleural effusion for differential diagnosis of benign and malignant pleural effusion Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology Year: 2008 Correlation between pleural fluid cytological yield and pleural tumour burden in malignant pleural effusions Source: Annual Congress 2010 - 100 years of thoracoscopy: still room for improvement? Year: 2010 Can VEGF be used in differential diagnosis of pleural effusions? Source: Eur Respir J 2007; 30: Suppl. 51, 565s Year: 2007 Combined pleural CRP and chest ultrosonography for discrimination between tuberculous and malignant pleural effusion Source: Eur Respir J 2005; 26: Suppl. 49, 414s Year: 2005 Utility of pleural fluid for predictive marker testing in malignant pleural effusion Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications Year: 2020 Separating malignant from nonmalignant pleural effusion on the basis of PO2 in pleural effusion Source: Eur Respir J 2003; 22: Suppl. 45, 541s Year: 2003